• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 RNA 的肿瘤药物治疗:从实验室到临床再到实验室。

RNA-based pharmacotherapy for tumors: From bench to clinic and back.

机构信息

Guangdong Key Laboratory for Research and Development of Natural Drugs, Guangdong Medical University, Zhanjiang, China; Southern Marine Science and Engineering Guangdong Laboratory Zhanjiang, The Marine Medical Research Institute of Guangdong Zhanjiang (GDZJMMRI), Guangdong Medical University, Zhanjiang, China.

Southern Marine Science and Engineering Guangdong Laboratory Zhanjiang, The Marine Medical Research Institute of Guangdong Zhanjiang (GDZJMMRI), Guangdong Medical University, Zhanjiang, China.

出版信息

Biomed Pharmacother. 2020 May;125:109997. doi: 10.1016/j.biopha.2020.109997. Epub 2020 Feb 13.

DOI:10.1016/j.biopha.2020.109997
PMID:32062550
Abstract

RNA therapy is a treatment that regulates cell proteins and cures diseases by affecting the metabolism of mRNAs in cells, which has cut a figure in the studies on various incurable illnesses like hereditary diseases, tumors, etc. In this review, we introduced the discovery and development of RNA therapy and discussed its classification, mechanisms, advantages, and challenges. Moreover, we highlighted how RNA therapy works in killing tumor cells as well as what progresses it has made in related researches. And the development of RNA anti-tumor drugs and the clinical trial process were also included.

摘要

RNA 疗法是一种通过影响细胞中 mRNA 的代谢来调节细胞蛋白并治疗疾病的治疗方法,它在遗传性疾病、肿瘤等各种不治之症的研究中崭露头角。在这篇综述中,我们介绍了 RNA 疗法的发现和发展,并讨论了它的分类、机制、优点和挑战。此外,我们还强调了 RNA 疗法如何杀死肿瘤细胞以及它在相关研究中取得的进展。还包括 RNA 抗肿瘤药物的发展和临床试验过程。

相似文献

1
RNA-based pharmacotherapy for tumors: From bench to clinic and back.基于 RNA 的肿瘤药物治疗:从实验室到临床再到实验室。
Biomed Pharmacother. 2020 May;125:109997. doi: 10.1016/j.biopha.2020.109997. Epub 2020 Feb 13.
2
The innovative evolution of cancer gene and cellular therapies.癌症基因和细胞疗法的创新演变。
Cancer Gene Ther. 2013 Mar;20(3):141-9. doi: 10.1038/cgt.2012.93. Epub 2013 Feb 1.
3
Natural antisense transcripts in the biological hallmarks of cancer: powerful regulators hidden in the dark.癌症生物学特征中的天然反义转录本:隐藏在黑暗中的强大调控因子。
J Exp Clin Cancer Res. 2020 Sep 14;39(1):187. doi: 10.1186/s13046-020-01700-0.
4
Better blocker: RNA interference dazzles research community.更好的阻断剂:RNA干扰令研究界眼前一亮。
J Natl Cancer Inst. 2003 Apr 2;95(7):500-2. doi: 10.1093/jnci/95.7.500.
5
Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter.由U6启动子转录的表皮生长因子受体反义RNA对人鳞状细胞癌体内生长的抑制作用。
J Natl Cancer Inst. 1998 Jul 15;90(14):1080-7. doi: 10.1093/jnci/90.14.1080.
6
Ex vivo and in vivo IGF-I antisense RNA strategies for treatment of cancer in humans.用于治疗人类癌症的体外和体内胰岛素样生长因子-I反义RNA策略。
Adv Exp Med Biol. 1998;451:27-34. doi: 10.1007/978-1-4615-5357-1_5.
7
New developments on targeted cancer therapy: Multi-faceted issues in targeted cancer therapy.靶向癌症治疗的新进展:靶向癌症治疗中的多方面问题。
Cancer Lett. 2017 Feb 28;387:1-2. doi: 10.1016/j.canlet.2016.12.016.
8
Progress in the development of nucleic acid therapeutics.核酸治疗学的发展进展。
Handb Exp Pharmacol. 2006(173):173-96. doi: 10.1007/3-540-27262-3_9.
9
In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.在癌症中,A-to-I RNA 编辑可能是驱动因素、乘客或机制。
Drug Resist Updat. 2017 May;32:16-22. doi: 10.1016/j.drup.2017.09.001. Epub 2017 Oct 4.
10
Engineering genomics. RNA antagonists--a new class of antisense drugs.工程基因组学。RNA拮抗剂——一类新型反义药物。
IEEE Eng Med Biol Mag. 2005 Jul-Aug;24(4):81-7. doi: 10.1109/memb.2005.1463401.

引用本文的文献

1
RNA-mediated inhibition of mitochondrial SHMT2 impairs cancer cell proliferation.RNA介导的线粒体丝氨酸羟甲基转移酶2抑制作用会损害癌细胞增殖。
Cell Death Discov. 2025 Aug 6;11(1):369. doi: 10.1038/s41420-025-02646-y.
2
mRNA vaccines and SiRNAs targeting cancer immunotherapy: challenges and opportunities.靶向癌症免疫治疗的mRNA疫苗和小干扰RNA:挑战与机遇
Discov Oncol. 2025 Jul 5;16(1):1265. doi: 10.1007/s12672-025-03070-5.
3
CHD1L in cancer and beyond: structure, oncogenic functions, and therapeutic potential.CHD1L在癌症及其他领域:结构、致癌功能及治疗潜力
J Exp Clin Cancer Res. 2025 May 30;44(1):167. doi: 10.1186/s13046-025-03428-1.
4
[Research advances of liposomes and exosomes in drug delivery and biomarker screening].脂质体与外泌体在药物递送和生物标志物筛选中的研究进展
Se Pu. 2025 May;43(5):472-486. doi: 10.3724/SP.J.1123.2024.08012.
5
Neoantigen immunotherapy: a novel treatment for bladder cancer.新抗原免疫疗法:一种治疗膀胱癌的新方法。
Explor Target Antitumor Ther. 2025 Jan 26;6:1002288. doi: 10.37349/etat.2025.1002288. eCollection 2025.
6
Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines.小核酸疗法全景:作为下一代药物从实验室走向临床
Signal Transduct Target Ther. 2025 Mar 10;10(1):73. doi: 10.1038/s41392-024-02112-8.
7
Cancer theragnostics: closing the loop for advanced personalized cancer treatment through the platform integration of therapeutics and diagnostics.癌症治疗诊断学:通过治疗与诊断的平台整合,为先进的个性化癌症治疗闭环。
Front Bioeng Biotechnol. 2025 Jan 17;12:1499474. doi: 10.3389/fbioe.2024.1499474. eCollection 2024.
8
mRNA vaccines in the context of cancer treatment: from concept to application.癌症治疗背景下的mRNA疫苗:从概念到应用
J Transl Med. 2025 Jan 6;23(1):12. doi: 10.1186/s12967-024-06033-6.
9
Unlocking the Potential of RNA Nanoparticles: A Breakthrough Approach to Overcoming Challenges in Colon Cancer Treatment.释放RNA纳米颗粒的潜力:一种克服结肠癌治疗挑战的突破性方法。
Curr Pharm Biotechnol. 2025;26(7):992-1013. doi: 10.2174/0113892010285554240303160500.
10
How snoRNAs can contribute to cancer at multiple levels.小核仁RNA(snoRNAs)如何在多个层面上促进癌症发展。
NAR Cancer. 2024 Feb 24;6(1):zcae005. doi: 10.1093/narcan/zcae005. eCollection 2024 Mar.